---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-21-007467"
form_type: "8-K"
ticker: "SLSN"
cik: "0000883107"
company_name: "SOLESENCE, INC."
filed_at: "2021-11-03T23:59:59+00:00"
generated_at: "2026-06-28T14:44:58.057329+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nanophase Q3 revenue $7.9M up 80% YoY; nine-month net income $2.7M

## Summary
- Q3 revenue $7.9M vs $3.9M YoY; nine-month revenue $22.1M vs $12.3M.
- Nine-month net income $2.7M ($0.04 EPS gain) vs $0.8M in 2020.
- Solésence beauty science nine-month revenue $13.4M, up 204% YoY, exceeding full-year 2020.
- Personal Care Ingredients revenue $5.3M (+28%); Advanced Materials $3.4M (-8%).
- Purchase orders in hand for $27M+; ~$10M applies to 2021 orders.

## SEC filing metadata
- accession: 0001171843-21-007467
- form_type: 8-K
- ticker: SLSN
- cik: 0000883107
- company_name: SOLESENCE, INC.
- filed_at: 2021-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883107/000117184321007467/0001171843-21-007467-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883107/000117184321007467/f8k_110321.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-21-007467
- JSON: https://secwatch.observer/filing/0001171843-21-007467.json
- Plain text: https://secwatch.observer/filing/0001171843-21-007467.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.